|
 |
| Diabetes News |
|
The most common of diseases of the pancreas is diabetes. As such, diabetes news is an important issue. More follows.
Diabetes News From Medical News Today
Immune System Tricked In Diabetic Mice-Fri, 21 Nov 2008 04:00:00 PST,The body's immune system hates strangers. When its security patrol spots a foreign cell, it annihilates it. This is the problem when people with type 1 diabetes undergo human islet cell transplantation. The islet cells from a donor pancreas produce robust amounts of insulin for the recipient -- often permitting independence from insulin therapy. However, the immune system tries to kill the new hard-working islets.
California School Nurses Org. Applauds Court Ruling - Agreement Allowing Non-Medical Personnel To Administer Diabetes Insulin Injections Overturned-Fri, 21 Nov 2008 02:00:00 PST,The California School Nurses Organization (CSNO) today issued the following statement regarding the California Superior Court ruling on licensed nurses administering insulin injections to students. "The California School Nurses Organization applauds Judge Lloyd G.
Steering Diabetes Patients Through The Sweetest Season-Fri, 21 Nov 2008 00:00:00 PST,November ushers in American Diabetes Month not only a time to be thankful for bustling basic and clinical research underway on the disease, but also the unofficial start of the holiday season. Between now and New Year's, people with diabetes must navigate a tempting course of sugar-centric festivities, maintaining a delicate nutritional balance against all odds. "It's possible," said Nicholas Jospe, M.D.
Researchers At IRB Barcelona Produce More Data On Key Genes In Diabetes-Fri, 21 Nov 2008 00:00:00 PST,One of the most reliable indicators to predict that a person will develop type 2 diabetes is the presence of insulin resistance. Insulin is produced in the pancreas and is the hormone responsible for ensuring that glucose reaches several tissues and organs in the body, such as muscles. Insulin resistance is characterized by the lack of tissue response to insulin and is counteracted by a greater production of insulin by the pancreas.
Successfull Completion Of Phase I Development Of In Vivo Glucose Sensing RFID Microchip-Thu, 20 Nov 2008 09:00:00 PST,VeriChip Corporation ("VeriChip") (NASDAQ:CHIP), a provider of RFID systems for healthcare and patient-related needs, and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding products, announced today that a significant milestone has been achieved toward the development of an in vivo glucose-sensing RFID microchip.
Study Finds HIV-Positive People Taking Some Antiretrovirals Are At Increased Risk Of Diabetes, Heart Disease-Thu, 20 Nov 2008 08:00:00 PST, HIV-positive people receiving treatment for the virus might be at an increased risk of developing heart disease and type 2 diabetes because some antiretroviral drugs can cause fat on the arms, legs, face and buttocks to move to the stomach, researchers at Australia's Garvan Institute said Monday, the
News From The American Chemical Society, Nov. 19, 2008-Thu, 20 Nov 2008 05:00:00 PST,Microcapsules act as "roach motel" to kill harmful bacteria Researchers in New Mexico and Florida are reporting development of microscopic particles that act as chemical booby traps for bacteria. The traps attract and kill up to 95 percent of nearby bacteria, including microbes responsible for worrisome hospital-based infections. The scientists describe their discovery as micro-sized "roach motels" for harmful bacteria.
Diabetes I And II In Mouse Model Treated By Garlic Chemical Tablet-Thu, 20 Nov 2008 04:00:00 PST,A drug based on a chemical found in garlic can treat diabetes types I and II when taken as a tablet, a study in the new Royal Society of Chemistry journal Metallomics says. When Hiromu Sakurai and colleagues from the Suzuka University of Medical Science, Japan, gave the drug orally to type I diabetic mice, they found it reduced blood glucose levels.
Genfit: New Phase I Clinical Trials With High-Dose Confirm The Excellent Tolerance Of GFT505 In Healthy Volunteers-Thu, 20 Nov 2008 04:00:00 PST,GENFIT (Alternext: ALGFT; ISIN: FR0004163111), a biopharmaceutical company at the forefront of research and development of drugs, focusing on early diagnosis and preventive treatment of cardiometabolic and neurodegenerative diseases, today announced the first data of a new Phase I clinical trials of GFT505, a drug candidate for the treatment of atherogenic dyslipidemia associated with pre-diabetes and diabetes (GFT505-1084 studies).
Physicians Should Closely Monitor Elderly Patients With Kidney Damage And Look For Signs Of Organ Failure-Thu, 20 Nov 2008 03:00:00 PST,Acute kidney injury (AKI) - which is often caused by trauma, illness, or surgery - predisposes elderly individuals to the most serious form of chronic kidney disease (CKD), known as end stage renal disease (ESRD), according to a study appearing in the January 2009 issue of the Journal of the American Society Nephrology (JASN). The findings indicate that close medical follow-up is important for maintaining the health of patients who have experienced kidney damage.
New Study Highlights Rising Number Of Type 2 Diabetes Patients In U.S., Increasing Complexity Of Treatments-Thu, 20 Nov 2008 01:00:00 PST,An increasing number of type 2 diabetes patients in the U.S. are being treated by a progressively complex mix of therapies, according to a study featured in Archives of Internal Medicine, a JAMA/Archives journal. The report is the first to be published by members of the Health Services Research Network (HSRN), a consortium of leading U.S. academicians that conducts independent research using IMS Health's evidence-based information to address key healthcare issues.
Joint Biomarker Research Related To Insulin Resistance And Diabetes - Metabolon And Joslin Diabetes Center-Thu, 20 Nov 2008 01:00:00 PST,Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and development, and the Joslin Diabetes Center, the world's preeminent diabetes research and clinical care organization, today announced a collaboration to carry out human clinical and animal studies in the area of insulin resistance and type 2 diabetes. This collaboration agreement includes a series of studies to be conducted using Metabolon's biochemical profiling technology.
Rise In Diabetes Among American Indian Youth Focus Of New National Education Program For Tribal Schools-Thu, 20 Nov 2008 01:00:00 PST,To address the growing epidemic of type 2 diabetes affecting American Indian youth, researchers from UNLV were part of a national collaboration with three federal agencies and eight tribal colleges to develop "Health is Life in Balance" - an innovative K-12 diabetes curriculum for tribal schools and schools with large American Indian/Alaska Native populations. The curriculum blends the science of diabetes with Native cultural teachings.
Genetic Testing For Diabetes Type 2 Still In Its Infancy-Thu, 20 Nov 2008 00:00:00 PST,Genetic testing for type 2 diabetes is still in its infancy, said researchers who did a US study that compared risk assessment based on screening for gene variants with more traditional risk factors like weight, blood pressure and blood sugar.
Diabetes Cost U.S. $218B In 2007, Report Finds-Wed, 19 Nov 2008 10:00:00 PST, Diabetes in 2007 cost the U.S. $218 billion in direct medical care and indirect costs, such as lost productivity, according to a report released on Tuesday, the AP/Raleigh News & Observer reports. For the report -- funded by Novo Nordisk, which manufactures insulin and diabetes medications -- researchers at the
California Diabetes & Family Medicine Experts Respond To Study Showing Diabetes-related Costs Are $218 Billion Annually-Wed, 19 Nov 2008 09:00:00 PST,A nationally prominent expert at treating diabetes, a chronic illness with potentially serious complications including blindness, limb amputation and death, said today many complications of diabetes are preventable and family physicians play a key role in preventing and controlling the disease.
CMS Will Not Cover Weight-Loss Surgeries For Non-Obese Diabetes Patients-Wed, 19 Nov 2008 07:00:00 PST, CMS on Monday said that it will not cover weight-loss surgery for Medicare beneficiaries with diabetes who are not dangerously overweight because there is not ample evidence proving the procedure can improve their health, Reuters/Yahoo! News reports.
JDRF Funded Research Shows Promise For Prevention, Reversal Of Type 1 Diabetes-Wed, 19 Nov 2008 05:00:00 PST,Researchers at the University of California, San Francisco have reported that two common cancer drugs have been used to block and reverse type 1 diabetes in mice. The JDRF-funded study, published in The Proceedings of the National Academy of Sciences, was led by Jeffrey Bluestone, Ph.D., director of the Diabetes Center at UCSF and an expert in the field of autoimmunity.
Consumer Health Sciences Presents Groundbreaking Data On The Impact Of Prediabetes-Wed, 19 Nov 2008 04:00:00 PST,Consumer Health Sciences, a leading international provider of comprehensive consumer health information and patient reported outcomes, presented groundbreaking data at the 15th Annual Conference of the International Society for Quality of Life Research, Montevideo, Uruguay, October 25, 2008. Findings demonstrated a significant impact of having prediabetes on the quality of life and work productivity of patients.
Noninvasive, Removable Medical Device Results In Substantial Weight Loss And Glucose Normalization In A Preclinical Model Of Obesity-Wed, 19 Nov 2008 04:00:00 PST,GI Dynamics, a medical device company pioneering the development of new approaches to treat obesity and type 2 diabetes, announced today a paper appearing in the advance online publication of the journal Obesity, which demonstrates that implantation of an innovative endoluminal sleeve mimics key, beneficial effects of Roux-en-Y gastric bypass (RYGB) surgery, inducing substantial weight loss and improved metabolic function in rats with diet-induced obesity.
XTL Biopharmaceuticals Announces Top-Line Results From The Bicifadine Phase 2b Study For Diabetic Neuropathic Pain-Wed, 19 Nov 2008 00:00:00 PST,XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB; TASE: XTL) announced the top-line results from the Bicifadine Phase 2b clinical trial for the treatment of diabetic neuropathic pain. The trial's primary objective was to compare the efficacy of two doses of Bicifadine against placebo in reducing pain associated with diabetic neuropathy. The primary endpoint of the study was the reduction in pain score during the course of treatment.
Study Finds Cost Of Diabetes In The United States Exceeds $217 Billion-Wed, 19 Nov 2008 00:00:00 PST,According to findings from a National Diabetes Economic Barometer study, undiagnosed, pre-diabetes and diabetes cost the United States an estimated $217.5 billion in 2007 due to higher medical expenditures and lost productivity. The research shows that beyond the estimated $174 billion that is widely-accepted as the cost of diagnosed diabetes in 2007, an additional $18 billion was spent on 6.
Why Should You Care About Diabetes? Kansas Department Of Health And Environment-Tue, 18 Nov 2008 08:00:00 PST,November is American Diabetes Month. To increase awareness of diabetes and its complications, the Kansas Department of Health and Environment (KDHE) and the American Diabetes Association (ADA) are asking the public "Why should you care about diabetes?" "Diabetes can lead to heart disease, stroke, kidney disease, blindness and amputations," said Roderick L. Bremby, Secretary of KDHE.
Type 1 Diabetes Prevented, Reversed By Two Cancer Drugs, UCSF Study Shows-Tue, 18 Nov 2008 08:00:00 PST,Two common cancer drugs have been shown to both prevent and reverse type 1 diabetes in a mouse model of the disease, according to research conducted at the University of California, San Francisco. The drugs - imatinib (marketed as Gleevec) and sunitinib (marketed as Sutent) - were found to put type 1 diabetes into remission in 80 percent of the test mice and work permanently in 80 percent of those that go into remission.
Statement From The American Diabetes Association On Court Ruling To Deny Care To Children With Diabetes-Tue, 18 Nov 2008 03:00:00 PST,The American Diabetes Association (ADA) is extremely disappointed with the recent California Superior Court ruling striking down a provision of an agreement between the ADA and the California Department of Education that would ensure students with diabetes are safe at school and during school activities. The provision at issue allowed for trained non-licensed school personnel in California to administer insulin when a nurse was not available.
|
|
|
| NEWS |
|
Ketchup And Pancreatic Cancer January 10, 2006
Cutting Pancreatic Cancer Risk December 31, 2005
One Pancreas Cancer Success December 30, 2005
$160K raised for Pancreatic Cancer December 22, 2005
Pancreatic Cancer Awareness December 15, 2005
Processed meats increase Pancreatic Cancer Risk October 5, 2005
Tarceva Benefits for Pancreatic Cancer. June 9, 2005
Doctors remove pancreas, but prevent diabetes. April 24, 2005
Ashcroft hospitalize for pancreatitis. March 5, 2005
|
|
|
